Litigation Details for TQ Delta LLC v. 2Wire Inc. (D. Del. 2013)

TQ Delta LLC v. 2Wire Inc. (D. Del. 2013)

Docket		Date Filed	2013-11-04
Court	District Court, D. Delaware	Date Terminated	2023-10-16
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Plaintiff	Referred To
Patents	10,556,010; 8,436,010; 8,445,003
Link to Docket	External link to docket

Details for TQ Delta LLC v. 2Wire Inc. (D. Del. 2013)

Date Filed	Document No.	Description	Snippet	Link To Document
2013-11-04				External link to document

TQ Delta LLC v. 2Wire Inc. Patent Litigation: Case No. 1:13-cv-01835

Last updated: September 30, 2026

TQ Delta LLC v. 2Wire Inc., No. 1:13-cv-01835-RGA, was a District of Delaware patent case involving DSL communications technology. TQ Delta accused 2Wire’s DSL customer-premises equipment of infringing patents directed to DSL transceiver operation, line diagnostics, impulse-noise protection, and related communications techniques. The case was part of TQ Delta’s broader enforcement campaign against manufacturers and suppliers of DSL modems and network equipment.

The public record is most significant for claim-construction and portfolio-enforcement analysis. The case did not produce a widely reported Federal Circuit merits decision establishing a final infringement or validity rule against 2Wire. Its commercial importance arose from the asserted DSL patent portfolio, the overlap between district-court litigation and inter partes review proceedings, and the role of 2Wire within the broader DSL equipment market.

What patents did TQ Delta assert against 2Wire?

TQ Delta’s asserted technology came from a family of patents covering DSL communication systems and methods. The case record and related TQ Delta proceedings identify patents in the portfolio including U.S. Patent Nos. 7,835,430, 8,090,008, 8,276,048, 8,625,778, and 8,718,158. The precise asserted-claim set must be determined from the operative pleadings and docket entries rather than from the existence of the broader portfolio.

Patent	General technology area	Commercial relevance
U.S. Patent No. 7,835,430	DSL line testing and diagnostics	Addresses equipment behavior during DSL-line testing and fault identification
U.S. Patent No. 8,090,008	DSL communication and transceiver operation	Relevant to modem architecture and protocol implementation
U.S. Patent No. 8,276,048	DSL signal processing and communications	Potentially implicated by DSL modem firmware and hardware
U.S. Patent No. 8,625,778	Impulse-noise protection and DSL transmission	Relevant to error protection and data recovery
U.S. Patent No. 8,718,158	DSL communication techniques	Later-expiring portfolio protection with potential system-level reach

The patents were not limited to a single modem model. Their claim scope could reach combinations of hardware, firmware, line-management software, and network-side equipment, depending on the asserted claims.

What was the central legal dispute in TQ Delta v. 2Wire?

The central dispute was whether 2Wire’s DSL equipment practiced the claimed methods and system limitations. TQ Delta’s theories were directed to the operation of DSL equipment rather than to a pharmaceutical composition or a standalone physical component.

The principal legal issues were:

1. Claim construction for technical DSL terms.
2. Whether 2Wire’s products performed the claimed signal-processing or diagnostic steps.
3. Whether the asserted claims were anticipated or obvious in view of earlier DSL standards and prior-art systems.
4. Whether claim limitations were satisfied by modem firmware, network equipment, or both.
5. Whether inter partes review proceedings affected the district-court case.

DSL patent litigation often turns on the division of functionality between customer-premises equipment and the telecommunications network. A product may contain the relevant code but may not independently perform every claimed step. Conversely, a method claim may be satisfied through coordinated operation between the modem and the network.

What was the procedural history of the case?

The action was filed in the U.S. District Court for the District of Delaware under Case No. 1:13-cv-01835-RGA. Judge Richard G. Andrews presided over the case. TQ Delta was the plaintiff and 2Wire Inc. was the defendant.

The case proceeded through the standard stages of patent litigation:

Procedural stage	Relevance
Complaint	Established TQ Delta’s infringement theories and identified accused 2Wire products
Patent disclosures	Defined the asserted claims, infringement contentions, and product mapping
Claim construction	Addressed the meaning of technical DSL claim language
Invalidity litigation	Allowed 2Wire to challenge novelty, obviousness, and claim scope
PTAB-related activity	Created possible overlap between district-court validity issues and inter partes review
Resolution	The public record does not reflect a widely reported final merits opinion against 2Wire

The case is cited in connection with a March 2015 District of Delaware claim-construction decision. Claim construction was material because the patents used specialized terminology relating to DSL transceivers, signal conditions, noise protection, and line behavior. In patent cases of this type, a narrow construction can limit infringement exposure while a broader construction can increase both infringement and validity risk.

Was there a Paragraph IV challenge in this case?

No. Paragraph IV is a Hatch-Waxman mechanism for challenging patents listed for a drug approved under the Federal Food, Drug, and Cosmetic Act. TQ Delta v. 2Wire was a conventional technology patent case involving DSL equipment. It did not involve an abbreviated new drug application, an Orange Book listing, a generic drug launch, or FDA exclusivity.

The relevant invalidity mechanisms were district-court defenses and, where applicable, inter partes review under the America Invents Act. The litigation therefore had no Paragraph IV notice-letter timeline, 30-month stay, New Chemical Entity exclusivity period, or generic-entry framework.

Did inter partes review affect the TQ Delta patent portfolio?

Yes. TQ Delta’s DSL patents were challenged in related Patent Trial and Appeal Board proceedings. The PTAB challenges focused on the validity of individual claims under anticipation and obviousness standards. Related TQ Delta appeals also reached the Federal Circuit, including proceedings involving the ’158 and ’778 patents.

The interaction between PTAB proceedings and district-court litigation affected litigation strategy in three ways:

• A successful inter partes review could eliminate claims before trial.
• A final written decision could create estoppel against certain invalidity arguments in later litigation.
• Institution and claim-survival outcomes could influence settlement leverage and licensing value.

The Federal Circuit’s later TQ Delta decisions show that the portfolio was subject to substantial appellate scrutiny. Those decisions should not be treated as final merits holdings in the 2Wire action unless the particular patent, claims, and judgment overlap.

What products were potentially implicated?

2Wire manufactured broadband networking equipment, including DSL gateways, modems, and related customer-premises equipment. The accused technology likely concerned equipment used in ADSL, VDSL, or other DSL deployments, including functionality implemented through firmware and coordinated with network-side DSL access equipment.

Potentially relevant product functions included:

• DSL initialization and line training.
• Impulse-noise protection.
• Data retransmission or error recovery.
• Signal-quality monitoring.
• Line diagnostics.
• Transceiver parameter negotiation.
• Coordination between customer-premises and central-office equipment.

An infringement analysis would require product-specific source code, technical manuals, firmware versions, standards compliance, and claim charts. The case number alone does not establish that every 2Wire product practiced every asserted claim.

How strong was TQ Delta’s patent position?

TQ Delta had a technically specialized portfolio with potential leverage against DSL equipment manufacturers because the patents addressed standards-adjacent functionality. Standards-related patents can create substantial commercial pressure when implementation options are limited or when equipment must interoperate with deployed telecommunications networks.

The portfolio also had weaknesses typical of DSL patent litigation:

• DSL technology had extensive pre-filing prior art.
• Industry standards could provide strong anticipation or obviousness references.
• Claim limitations had to be mapped to specific hardware or firmware operations.
• Method claims could raise questions concerning divided infringement.
• PTAB review created a second validity forum.
• Patent expiration reduced the period available for damages and licensing.

Portfolio strength therefore depended on claim-by-claim survival, not merely on the number of issued patents.

What was the commercial significance for 2Wire?

2Wire’s exposure was connected to the installed base of DSL gateways and the company’s position as an equipment supplier. Potential damages could have been based on sales of accused products, reasonable royalties, or other legally available remedies. Enhanced damages would have required a showing of willful infringement under the applicable legal standard.

The commercial risk extended beyond direct sales. A patent license or settlement could affect:

• Existing product inventory.
• Firmware updates.
• Support obligations.
• Customer indemnification.
• Parent-company or successor exposure.
• Procurement requirements for telecommunications carriers.
• Product redesign and interoperability testing.

2Wire was acquired by Pace plc before Pace was later acquired by ARRIS. That corporate history is relevant to diligence involving successor liability, indemnification, and ownership of accused product lines. It does not by itself establish that any successor assumed liability for the litigation.

Was the case settled?

The public record does not provide a widely reported merits judgment establishing liability, damages, or an injunction against 2Wire. Nor is there a widely reported published settlement agreement identifying payment terms, a cross-license, or continuing obligations.

A docket termination or stipulated dismissal, if entered, should not be interpreted as an admission of infringement or invalidity. Patent cases commonly end through confidential settlement, license, dismissal, or portfolio restructuring without public disclosure of economic terms.

What litigation risks remain for companies using the same DSL technology?

Companies using DSL functionality covered by the same patent families could face residual risk even after the 2Wire case ended. The main risk categories are:

Risk category	Assessment
Direct infringement	Depends on whether the accused product performs every asserted claim limitation
Indirect infringement	Depends on knowledge, inducement evidence, and customer use
Divided infringement	Relevant where steps are split between modem and network equipment
Validity	Depends on prior art, PTAB outcomes, and surviving claim scope
Damages	Depends on sales period, notice, marking, and royalty evidence
Injunction risk	Generally depends on patent expiration, product substitutability, and equitable factors
Successor exposure	Relevant to acquired product lines and contractual indemnities
Standards dependence	Increases practical redesign and interoperability costs

For diligence, the critical distinction is between a patent family’s existence and an enforceable, unexpired claim that reads on the current product. Patent expiration dates, terminal disclaimers, maintenance-fee status, reexamination or PTAB outcomes, and claim amendments must be reviewed patent by patent.

How does TQ Delta v. 2Wire compare with drug patent litigation?

The case has no direct analogue to pharmaceutical exclusivity litigation. The following comparison illustrates the legal framework:

Issue	TQ Delta v. 2Wire	Drug patent litigation
Technology	DSL communications equipment	Active pharmaceutical ingredients, formulations, methods
Regulatory pathway	No FDA approval framework	NDA, ANDA, BLA, or biosimilar pathway
Patent challenge	District-court invalidity and PTAB review	Paragraph IV, post-grant review, inter partes review
Exclusivity	Patent term only	Patent term plus FDA regulatory exclusivity
Product entry	Equipment sales and redesign	Generic or biosimilar launch
Orange Book	Not applicable	Applies to listed NDA patents
Settlement controls	General patent law and antitrust principles	Hatch-Waxman and FTC scrutiny may apply

Key Takeaways

• TQ Delta v. 2Wire, No. 1:13-cv-01835-RGA, was a District of Delaware DSL patent case.
• TQ Delta asserted patents covering DSL communications, diagnostics, signal processing, and impulse-noise protection.
• The case involved claim construction, infringement, invalidity, and related PTAB activity.
• It was not a Paragraph IV, Orange Book, biosimilar, or FDA exclusivity case.
• The public record does not establish a widely reported final merits judgment against 2Wire.
• TQ Delta’s portfolio had potential standards-adjacent leverage but faced substantial prior-art, claim-construction, and PTAB validity risks.
• Any current freedom-to-operate analysis requires patent-specific review of expiration, surviving claims, product implementation, and successor-company obligations.

FAQs

Did TQ Delta seek an injunction against 2Wire?

The case was capable of supporting injunctive relief under ordinary patent remedies, but no widely reported final injunction against 2Wire is identified in the public record.

Were 2Wire DSL modems found to infringe TQ Delta patents?

No widely reported final merits decision establishes that 2Wire’s DSL modems infringed the asserted TQ Delta patents.

Are TQ Delta’s DSL patents still enforceable?

Enforceability depends on the specific patent, expiration date, maintenance-fee status, claim amendments, and post-grant proceedings. Portfolio-level ownership does not establish that every patent remains enforceable.

Did the 2Wire case involve ARRIS?

2Wire was acquired by Pace, and Pace was later acquired by ARRIS. That corporate sequence is relevant to successor and indemnification analysis, but it does not alone establish liability in the TQ Delta litigation.

Can TQ Delta’s DSL patents affect current broadband equipment?

Potentially. Current exposure depends on whether unexpired claims cover the specific DSL implementation and whether the relevant products remain commercially deployed. Fiber, cable, fixed-wireless, and newer broadband architectures require separate claim analysis.

References

1. TQ Delta LLC v. 2Wire, Inc., No. 1:13-cv-01835-RGA, U.S. District Court for the District of Delaware, docket record.

2. TQ Delta LLC v. 2Wire, Inc., 2015 WL 1383960 (D. Del. Mar. 25, 2015).

3. TQ Delta LLC v. DISH Network LLC, 929 F.3d 1350 (Fed. Cir. 2019).

4. U.S. Patent and Trademark Office. (2014-2019). Patent Trial and Appeal Board proceedings involving TQ Delta LLC patents.

5. U.S. Patent and Trademark Office. Patent Center and Patent Assignment records for U.S. Patent Nos. 7,835,430, 8,090,008, 8,276,048, 8,625,778, and 8,718,158.